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T
ln this issue of the Journal, Spazzolini et al. (1) report a
tudy from several primary research centers in arrhythmo-
enic channelopathies of severe clinical manifestations of
ong QT syndrome in the infant. Before discussing their
mportant and possibly controversial findings, it is worth
ommending the authors—several of whom are established
xperts in their own right in the field of cardiac channelopa-
hy research—for a truly collaborative, international effort.
hey have succeeded in characterizing an exceedingly rare
ird: the infant suffering from lethal, congenital arrhythmia.
This study draws on over 3,000 patients recorded in the
nternational Long QT Registry, singling out those few
ho are symptomatic in the first year of their life. The
ortality rate in this group is known to be high from
necdotes and small series, with sinus bradycardia and
onduction defects often complicating the clinical presen-
ation (2). The data presented here strongly confirm that
linical assessment, with most infant long QT patients
resenting with death or aborted cardiac arrest and a high
ikelihood of recurrent arrest among the survivors. There are
elated questions that this article raises but does not com-
letely answer. First, why is the lethality of long QT
yndrome so much higher in infants than in older patients?
nd second, what are the implications for clinical manage-
ent of these patients?
See page 832
The impressive lethality of infantile long QT syndrome is
ikely due to a variety of pathophysiological and clinical
actors. Of all long QT patients, only infants express the full
ange of mutations compatible with survival to delivery,
ecause those most severely affected die young and never
ontribute to the mortality recorded in older groups. Al-
hough controversy has existed regarding the importance of
hannelopathic mutations in the pathogenesis of sudden
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.s
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eceived an honorarium from Boston Scientific.nfant death syndrome (SIDS), recent research suggests that
pproximately 10% of infants who die in this manner have
mutation that could be responsible for arrhythmic death
3). The distribution of long QT genotypes in infancy is not
ell-characterized, but reports on the genotype distribution
mong SIDS victims suggests that it might differ substan-
ially from that observed in older populations, perhaps with
higher frequency of uncommon lethal genotypes or more
ethal expression of common mutations (4,5). Continued
ccumulation of clinically well-characterized genotype da-
abases will ultimately answer this question. It will be of
articular interest to determine whether highly lethal mu-
ations seen in young patients maintain their high-risk
henotype among patients surviving to older ages.
Further complicating management of the infant with
ong QT syndrome and plausibly contributing to its lethality
s the developmental immaturity of the infant brainstem.
ympathovagal cardiovascular control evolves rapidly and
symmetrically during gestation and infancy (6). Cardiac
utonomic input in infants might be further affected by
mmaturity of respiratory regulation and sleep state, which
re tightly coupled to autonomic efferent activity. Auto-
omic traffic to the heart is a significant pathogenetic factor
n long QT expression in older patients, and there is
vidence from the SIDS published reports to suggest that it
ight have a similarly important role in infants, perhaps in the
orm of autonomic instability (7). It is fair to assume, in any
vent, that infants are very different from the adult patient with
espect to their cardiac autonomic environment. As a result,
ne could speculate that infants might be more prone to fail in
esponse to challenges to their repolarization reserve, given a
ertain genotype, or that they might respond less favorably to
eta-blockade, a therapy whose value in infants is imputed
rom older patients and which was not noted to be protective
n this limited study.
In addition to these important potential physiological
ifferences, infants live in a somewhat isolated world with
espect to presenting symptoms. In general, infants present
sicker” than adults, with major or even catastrophic events.
hey have had less time to be diagnosed and possess only a
imited vocabulary to communicate “symptoms” such as
yncope, which is notoriously vaguely defined in infancy.
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August 25, 2009:838–9 Long QT Syndrome in Infancydditionally, life-threatening disease is generally rare in
nfancy, and so the clinical suspicion for diseases such as
ong QT syndrome is low. Thus, there will be fewer patients
dentified at this age with “mildly” symptomatic and asymp-
omatic disease. This is especially important for this specific
tudy group—the International Long QT Registry—which
epresents an integration of clinical experience dating back
o a time (not long ago) when patients were more frequently
dentified by symptomatic presentation (8). The evolution
f QT case-finding to include phenotypic and genotypic
nalysis of asymptomatic individuals in affected kindreds
nd the recent increase in electrocardiographic (ECG)
creening among groups conceived to be “at risk” due to
hannelopathy (e.g., those receiving potentially arrhythmo-
enic drugs for other indications) has diluted somewhat the
henotypic severity of the disease. As ECG screening is
erformed on a wider population base—including perhaps
ealthy, asymptomatic infants—this trend will continue,
nd the population known as “long QT patients” will
ncreasingly represent the full spectrum of genotypic varia-
ion in the disease.
Even taking these potential epidemiological confounders
nto consideration, the severity of long QT syndrome in
nfancy seems striking. The data presented in this study has
mportant and worrisome implications for therapy. First, the
uthors bring into question the value of standard and most
idely accepted prophylactic therapy in older patients,
nding that administration of beta-blockade was not clearly
ssociated with survival benefit in the sickest patients.
lthough evidence for beta-blocker efficacy in this study is
ot encouraging, many will continue to use these agents in
nfants as we do for most first presentations of long QT
yndrome, because they are generally well-tolerated, the
egative evidence against their use in this study is not
tatistically strong, and as individual patients grow, eventu-
lly they will inhabit a population segment for which
eta-blockers have been shown to be useful.
Lacking compelling evidence for beta-blockers in these
atients, the authors suggest consideration of cardiac sym-
athetic denervation, also of proven value in older popula-
ions. Most clinicians are inclined to avoid destructive
urgical intervention for patients of this age when possible.
iven the relative autonomic immaturity of these patients
nd the very limited experience to date with sympathectomy
n infants and toddlers, it would seem prudent to exercise
aution in recommending it as a preferred therapy and note
hat the differences in pathophysiology affecting response of
hese patients to beta-blockade might not only be to some
xtent maturational but could also limit the utility of
enervative therapy by similar mechanisms. Unfortunately,
e lack proven device therapy for mitigation of sudden
eath risk in this age group—although ad hoc efforts have
een made in difficult cases, implantable cardioverter- Kefibrillators truly suitable for use in high-risk small chil-
ren have yet to be introduced. Because few patients need
uch therapy, access to such highly specialized technology
ill be determined only by affirmative health policy deci-
ions promoting the availability of orphan devices.
Other important health policy issues are raised by the
ccurrence of lethal long QT syndrome in our young
opulations. It is legitimate to ask whether all infants should
e electrocardiographically screened early in life to identify
his malignant syndrome. This is a matter of urgent debate,
ecause significant resource allocation issues are implied by
uch a decision. Such programs will undoubtedly identify
atients with long QT syndrome, but many of these will be
henotypically borderline, asymptomatic patients—some
ith a mutation, others without—who are likely to have
ood outcomes regardless of early identification. Addition-
lly, at least according to the data presented here, standard
rophylactic medical therapies might be less efficacious in
his population as compared with older groups. Both of
hese issues will decrease the cost-effectiveness of
opulation-based ECG screening. Thus, it is important to
onsider this question in terms of public health policy, as
ell as in the context of individual patient care (9).
eprint requests and correspondence: Dr. John Triedman, 300
ongwood Avenue, Boston, Massachusetts 02115. E-mail:
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